Zhu, Feng
Grier, Harrison A.
Tandon, Raghav
Cai, Changjia
Agarwal, Anjali
Giovannucci, Andrea http://orcid.org/0000-0002-7850-444X
Kaufman, Matthew T. http://orcid.org/0000-0002-8072-023X
Pandarinath, Chethan http://orcid.org/0000-0003-1241-1432
Funding for this research was provided by:
Arnold and Mabel Beckman Foundation
Alfred P. Sloan Foundation
National Science Foundation (NSF NCS 1835390, NCS 1835364)
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (R01 NS121535, R21 NS116311)
The University of Chicago The Neuroscience Institute at The University of Chicago
U.S. Department of Health & Human Services | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (K12HD073945)
U.S. Department of Health & Human Services | NIH | NIH Office of the Director (DP2 NS127291)
Simons Foundation (Simons-Emory International Consortium on Motor Control)
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (RF1 DA055667)
U.S. Department of Health & Human Services | NIH | National Center for Advancing Translational Sciences (UL1-TR002378)
Emory Neuromodulation and Technology Innovation Center (ENTICe) The Emory School of Medicine Imagine, Innovate and Impact (I3) Funds Emory Udall Center of Excellence for Parkinson’s Research
Article History
Received: 18 August 2021
Accepted: 23 September 2022
First Online: 24 November 2022
Competing interests
: One of the innovations detailed in the manuscript, Selective Backpropagation Through Time (SBTT), is covered in a provisional patent: C.P., M.K., F.Z., A.G., A.S. Selective backpropagation through time. US patent application number 63/262.704, filed as provisional patent. C.P. is a consultant to Synchron and Meta (Reality Labs). These entities did not support this work, have a role in the study or have any financial interests related to this work.